Viking Therapeutics
VKTX
VKTX
372 hedge funds and large institutions have $6.56B invested in Viking Therapeutics in 2024 Q1 according to their latest regulatory filings, with 201 funds opening new positions, 77 increasing their positions, 87 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
372
Holders Change
+176
Holders Change %
+89.8%
% of All Funds
5.39%
Holding in Top 10
13
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+550%
% of All Funds
0.19%
New
201
Increased
77
Reduced
87
Closed
25
Calls
$730M
Puts
$496M
Net Calls
+$235M
Net Calls Change
+$199M
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$294M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$110M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$85.1M |
| 5 |
PA
Perceptive Advisors
New York
|
+$81.5M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$332M |
| 2 |
State Street
Boston,
Massachusetts
|
-$197M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$175M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$173M |
| 5 |
Morgan Stanley
New York
|
-$166M |
